{"changeSha256":"07e06a8f0c34c8610d6221a542ed07b47ce11f9c441ade1967f515f8a91e98df","changedAt":"2026-09-15","changedFields":[{"after":"China: approval reported by local government sources","before":"Investigational","field":"Status"},{"after":"approval-reported","before":"investigational","field":"Status classification"},{"after":"A June 2025 Suzhou Industrial Park regulator report describes Chinese approval of mazdutide injection for long-term weight management in adults with obesity or overweight. A December 2025 Suzhou government report describes approved diabetes and weight-management indications in China.","before":"A metabolic peptide candidate. This profile cites a ClinicalTrials.gov study record that was not yet recruiting.","field":"Profile summary"},{"after":"These are attributable local-government reports, not the national approval decision or complete prescribing information. The national decision and exact indication conditions remain to be reconciled. This account does not establish approval in the United States or other jurisdictions.","before":"ClinicalTrials.gov lists a West China Hospital study as not yet recruiting, updated July 21, 2026.","field":"Evidence note"},{"after":"ctg-nct07718126-v1, sipac-mazdutide-approval-report-2025, suzhou-mazdutide-indications-report-2025","before":"ctg-nct07718126-v1","field":"Cited source records"},{"after":"name: ctg-nct07718126-v1; aliases: ctg-nct07718126-v1; category: ctg-nct07718126-v1; status: sipac-mazdutide-approval-report-2025, suzhou-mazdutide-indications-report-2025; summary: sipac-mazdutide-approval-report-2025, suzhou-mazdutide-indications-report-2025; evidenceNote: sipac-mazdutide-approval-report-2025, suzhou-mazdutide-indications-report-2025","before":"name: ctg-nct07718126-v1; aliases: ctg-nct07718126-v1; category: ctg-nct07718126-v1; status: ctg-nct07718126-v1; summary: ctg-nct07718126-v1; evidenceNote: ctg-nct07718126-v1","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/mazdutide/versions/3/","version":3},"id":"profile:mazdutide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"corrected","notice":"The previous profile used an unqualified investigational status. We added dated local-government reports of approval in China while keeping national decision and label verification open. Earlier trial-based versions remain available.","peptideSlugs":["mazdutide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/mazdutide/v2.json","sha256":"fcd5ab35465c2551137eb05dcfd794df77591257017d872537ed8cc624b55f5f"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/mazdutide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"sipac-mazdutide-approval-report-2025","name":"Suzhou Industrial Park Market Supervision Bureau","sourceClass":"A","title":"June 27, 2025 government report of Chinese approval for mazdutide weight management","url":"https://www.sipac.gov.cn/szgyyqscjgj/gzdt/202506/a5e5b5345b1b422c84bc7eed401e7df7.shtml","verifiedAt":"2026-09-15"},{"id":"suzhou-mazdutide-indications-report-2025","name":"Suzhou Municipal Government","sourceClass":"A","title":"December 19, 2025 government report describing Chinese mazdutide diabetes and weight indications","url":"https://www.suzhou.gov.cn/szsrmzf/ylfw/202512/0bd9b32d114d4c50b00e7e1860c99b13.shtml","verifiedAt":"2026-09-15"}],"subject":{"slug":"mazdutide","type":"profile"}}